Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Pathilon: Full Drug Profile
Medically reviewed by Min Clinic Staff | Updated: January 2026
Pathilon - General Information
Pathilon is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Pathilon is an antimuscarinic, anticholinergic drug.
Pharmacology of Pathilon
Pathilon is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Pathilon is an antimuscarinic, anticholinergic drug.
Additional information about Pathilon
- Pathilon Indication
Used as an adjunct in the treatment of peptic ulcer disease
- Mechanism Of Action
- Pathilon binds the muscarinic acetylcholine receptor. It may block all three types of muscarinic receptors including M-1 receptors in the CNS and ganglia, M-2 receptors in the heart (vagus) and M-3 receptors at the parasympathetic NEJ system. The muscarinic acetylcholine receptors mediate various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Pathilon inhibits vagally mediated reflexes by antagonizing the action of acetylcholine. This in turn reduces the secretion of gastric acids in the stomach.
- Generic Name
- Tridihexethyl
- Drug Category
- Antispasmodics; Anticholinergic Agents
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Tridihexethyl
- Pathilon; Propethonum;
- Chemical IUPAC Name
- (3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium
- Chemical Formula
- C21H36NO+
- Organisms Affected
- Humans and other mammals
